Nalaganje...

Age Disparity in the Dissemination of Imatinib for Treating Chronic Myeloid Leukemia

BACKGROUND: Imatinib is a highly effective treatment for chronic myeloid leukemia (CML) that was approved by the Food and Drug Administration in 2001, and thereafter rapidly became front line therapy. This study characterized the prevailing chronic myeloid leukemia therapies in the United States and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Wiggins, Charles L., Harlan, Linda C., Nelson, Harold E., Stevens, Jennifer L., Willman, Cheryl L., Libby, Edward N., Hromas, Robert A.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2913144/
https://ncbi.nlm.nih.gov/pubmed/20670732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjmed.2010.03.018
Oznake: Označite
Brez oznak, prvi označite!